| Literature DB >> 31255854 |
Xiyan Mu1, Chuanyuan Ji2, Qi Wang1, Kun Liu1, Xinyu Hao2, Guanhua Zhang1, Xiaowei Shi1, Yuqian Zhang1, Frank J Gonzalez3, Qiao Wang4, Yangang Wang5.
Abstract
Analysis of the properties of the tongue has been used in traditional Chinese medicine for disease diagnosis. Notably, tongue analysis, which is non-invasive and convenient compared with gastroscopy and pathological examination, can be used to assess chronic gastritis (CG). In order to find potential diagnostic biomarkers and study the metabolic mechanisms of the endogenous small molecules in the tongue coating related to CG, a non-targeted metabolomic analysis method was developed using ultra high performance liquid chromatography combined with quadrupole time-of-flight mass spectrometry (UHPLC-Q/TOF-MS). It was performed using two different columns in positive and negative ion scanning modes separately. The stability of the samples was evaluated and the age and gender factors of the subjects were excluded to ensure the reliability of the data in this study. Finally, under the four analysis models, 130, 229, 113 and 92 differential compounds were found using multivariate statistical methods respectively. 37 potential biomarkers were putatively identified after removing the duplicate compounds and five potential diagnostic biomarkers were putatively identified by receiver operating characteristic (ROC) curve analysis, including inosine, oleamide, adenosine, N-acetylglucosamine (GlcNAc) and xanthine. The main metabolic pathways associated with CG were purine metabolism, amino acid metabolism, sphingolipid metabolism and energy metabolism, which suggested that oxygen free radicals and energy metabolism were altered in patients with CG. These results provided a potential new basis for the quantitative diagnosis and pathogenesis of CG.Entities:
Keywords: Chronic gastritis; Diagnostic biomarker; Metabolomics; Tongue coating; UHPLC-Q/TOF-MS
Mesh:
Substances:
Year: 2019 PMID: 31255854 PMCID: PMC7383221 DOI: 10.1016/j.jpba.2019.06.025
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935